Results 191 to 200 of about 4,342,004 (341)
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source
Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast Cancer. [PDF]
Seguin-Devaux C +11 more
europepmc +1 more source
Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases [PDF]
Sofia Mortensen +2 more
openalex +1 more source
Decreased Serum 5‐HT: Clinical Correlates and Regulatory Role in NMJ of MG
ABSTRACT Objective Although 5‐Hydroxytryptamine (5‐HT) indirectly stimulates muscle contraction and participates in regulating Acetylcholine receptor (AChR) cluster homeostasis in cellular, animal, and clinical studies, evidence regarding its potential to modulate muscle contraction in myasthenia gravis (MG) remains limited.
Xinru Shen +18 more
wiley +1 more source
Breaking the cycle: immune complexes, complement activation, and novel immunotherapies in lupus nephritis. [PDF]
Dong C +7 more
europepmc +1 more source
A NOVEL MODELING APPROACH TO ELUCIDATE THE ROLE OF AUTOANTIBODIES IN COMPLEMENT ACTIVATION IN SLE [PDF]
David S. Pisetsky +11 more
openalex +1 more source
Complement activation in patients with diabetic nephropathy.
Xiao Li, D. Chang, Min Chen, M. Zhao
semanticscholar +1 more source
ABSTRACT Aims This study aimed to explore the relationship between stress‐induced hyperglycemia (SIH) and in‐hospital medical complications in patients with acute stroke. Methods We enrolled 865,765 patients with acute stroke from the Chinese Stroke Center Alliance cohort.
Xintong Song +6 more
wiley +1 more source
Alternative pathway-mediated tubular complement activation in human proteinuric kidney diseases: a proof-of-concept study. [PDF]
Alkaff FF +7 more
europepmc +1 more source

